Use of whole-genome sequencing to distinguish relapse from reinfection in a completed tuberculosis clinical trial

BACKGROUND: RIFAQUIN was a tuberculosis chemotherapy trial in southern Africa including regimens with high-dose rifapentine with moxifloxacin. Here, the application of whole-genome sequencing (WGS) is evaluated within RIFAQUIN for identifying new infections in treated patients as either relapses or...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:BMC Med
Prif Awduron: Witney, Adam A., Bateson, Anna L. E., Jindani, Amina, Phillips, Patrick P. J., Coleman, David, Stoker, Neil G., Butcher, Philip D., McHugh, Timothy D.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2017
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5371199/
https://ncbi.nlm.nih.gov/pubmed/28351427
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-017-0834-4
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg